Home › Diffuse Large B-Cell Lymphoma › North Carolina › Winston-Salem
Diffuse Large B-Cell Lymphoma clinical trials in Winston-Salem, NC
5 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Winston-Salem (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RecruitingPhase 2
- Novant Health Forsyth Medical Center ( Site 0206), Winston-Salem
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
RecruitingPhase 1
- Wake Forest University Health Sciences, Winston-Salem
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RecruitingPhase 2
- Wake Forest University Health Sciences, Winston-Salem
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Atrium Health Wake Forest Baptist, Winston-Salem
Diffuse Large B-Cell Lymphoma trials in other cities
- New York City, NY20 studies
- Baldwin Park, CA19 studies
- Los Angeles, CA18 studies
- Houston, TX18 studies
- Chicago, IL18 studies
- Milwaukee, WI17 studies
- Nashville, TN17 studies
- Boston, MA17 studies
- Philadelphia, PA15 studies
- Durham, NC15 studies
- Portland, OR15 studies
- Cleveland, OH13 studies
Other studies in Winston-Salem
- Acute Myeloid Leukemia20 studies
- Cancer (all types)19 studies
- Multiple Myeloma16 studies
- Breast Cancer15 studies
- Cardiovascular Disease13 studies
- Non-Small Cell Lung Cancer11 studies
- COPD11 studies
- Ovarian Cancer10 studies
- Myeloproliferative Neoplasms9 studies
- Myelofibrosis9 studies
- Type 2 Diabetes9 studies
- Myelodysplastic Syndromes9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.